Ascendis Pharma A/S Increase Decrease Through Net Exchange Differences Other Provisions
Ascendis Pharma A/S (ASND) reported Increase Decrease Through Net Exchange Differences Other Provisions of -EUR 10.34 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions · last filed 2026-02-11
| Period end | Increase Decrease Through Net Exchange Differences Other Provisions 12 month |
|---|---|
| 2025-12-31 | -10.34M EUR 20-F · filed 2026-02-11 |
| 2024-12-31 | 4.46M EUR 20-F · filed 2025-02-12 |
| 2023-12-31 | -1.01M EUR 20-F · filed 2024-02-07 |